Humate-P® AHF/VWF complex

Hemophilia A

Humate-P is indicated for treatment and prevention of bleeding in adults with hemophilia A (classical hemophilia).

Von Willebrand Disease (VWD)

Humate-P is also indicated in adult and pediatric patients with von Willebrand disease (VWD) for: (1) treatment of spontaneous and trauma-induced bleeding episodes, and (2) prevention of excessive bleeding during and after surgery. This applies to patients with severe VWD as well as patients with mild to moderate VWD where use of desmopressin (DDAVP) is known or suspected to be inadequate. Controlled clinical trials to evaluate the safety and efficacy of prophylactic dosing with Humate-P to prevent spontaneous bleeding have not been conducted in VWD subjects (see PI).

For indications, dosing and other information, please refer to the prescribing information.

Humate-P® AHF/VWF Complex ‐ CSL Behring

Size:
500 rcu, 5 mL vial
NDC #:
63833-0615-02
Download:
PI
Size:
1000 rcu, 10 mL vial
NDC #:
63833-0616-02
Download:
PI
Size:
2500 rcu, 15 mL vial
NDC #:
63833-0617-02
Download:
PI